Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations

Lung cancer is a dismal disease as a leading cause of overall cancer death, but the development of immune checkpoint inhibitors (ICIs) in driver gene mutation negative metastatic non-small cell lung cancer (NSCLC) is changing the paradigm of lung cancer treatment. Recently, ICIs are expanding their...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Jae Kyeom, Choi, Juwhan, Lee, Sung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636541/
https://www.ncbi.nlm.nih.gov/pubmed/37939663
http://dx.doi.org/10.3904/kjim.2023.345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636541/
https://www.ncbi.nlm.nih.gov/pubmed/37939663
http://dx.doi.org/10.3904/kjim.2023.345

Ejemplares similares